Beyond obesity, GLP-1s are being explored in MASH, cardiovascular diseases, OSA, and neurodegenerative disorders, making this one of the most versatile drug classes in modern medicine
However, Zepbound belongs to a different category of dual GIP and GLP-1 agonists, which only Zepbound possesses, making this product the only weight loss pill that has both effects
Additional studies in overweight pregnant women have reported reduced incidence of gestational diabetes, improved lipid and glycemic profiles, and improved blood pressure control in women with PE receiving resveratrol supplementation 38
Patients should also ask what would make peptide therapy inappropriate
Topical GHK-Cu should only be considered as part of a supervised wound-care strategy under qualified healthcare guidance